These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 6796194)

  • 21. Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats.
    Fink JS; Smith GP
    Brain Res; 1980 Oct; 199(2):359-84. PubMed ID: 7417789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of catecholamine terminals and intrinsic neurons of the ventral tegmentum in self-stimulation investigated in neonatally dopamine-depleted rats.
    Takeichi T; Kurumiya S; Umemoto M; Olds ME
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1101-9. PubMed ID: 3086902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of amphetamine isomers to decrease hyperactivity in developing rats.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1982 Jul; 17(1):5-9. PubMed ID: 7122666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional changes induced by neonatal cerebral 6-hydroxydopamine treatment: effects of dose levels on behavioral parameters.
    Luthman J; Bassen M; Fredriksson A; Archer T
    Behav Brain Res; 1997 Jan; 82(2):213-21. PubMed ID: 9030403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Spontaneous motor activity and radial-maze learning in rats neonatally treated with 6-hydroxydopamine].
    Iwasaki T; Takasuna M
    Yakubutsu Seishin Kodo; 1986 Dec; 6(4):381-8. PubMed ID: 3103348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F; Ettenberg A; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological investigation on the role of dopamine in the rat locus coeruleus.
    Milon H; McRae-Degueurce A
    Neurosci Lett; 1982 Jun; 30(3):297-301. PubMed ID: 6810240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning.
    Archer T; Danysz W; Fredriksson A; Jonsson G; Luthman J; Sundström E; Teiling A
    Pharmacol Biochem Behav; 1988 Oct; 31(2):357-64. PubMed ID: 3149743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment.
    Luthman J; Fredriksson A; Lewander T; Jonsson G; Archer T
    Psychopharmacology (Berl); 1989; 99(4):550-7. PubMed ID: 2594922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of central dopamine depletion on the d-amphetamine discriminative stimulus in rats.
    Woolverton WL; Cervo L
    Psychopharmacology (Berl); 1986; 88(2):196-200. PubMed ID: 3006111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.
    Davids E; Zhang K; Kula NS; Tarazi FI; Baldessarini RJ
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1097-102. PubMed ID: 12023542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microdialysates of amines and metabolites from core nucleus accumbens of freely moving rats are altered by dizocilpine.
    Hatip-Al-Khatib I; Mishima K; Iwasaki K; Fujiwara M
    Brain Res; 2001 May; 902(1):108-18. PubMed ID: 11376600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperactivity in neonatally dopamine-lesioned rats requires residual activity in mesolimbic dopamine neurons.
    Luthman J; Lindqvist E; Ogren SO
    Pharmacol Biochem Behav; 1995 May; 51(1):159-63. PubMed ID: 7617728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of dopamine in the development of spontaneous hypertension.
    van den Buuse M; Versteeg DH; de Jong W
    Hypertension; 1984; 6(6 Pt 1):899-905. PubMed ID: 6519747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat.
    Hard E; Ahlenius S; Engel J
    Psychopharmacology (Berl); 1983; 80(3):269-74. PubMed ID: 6412273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overeating after midbrain 6-hydroxydopamine: prevention by central injection of selective catecholamine reuptake blockers.
    Hernandez L; Hoebel BG
    Brain Res; 1982 Aug; 245(2):333-43. PubMed ID: 6812851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Right/left discrimination learning in rat pups neonatally treated with 6-hydroxydopamine].
    Takasuna M; Iwasaki T
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):315-21. PubMed ID: 2123587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup.
    Shaywitz BA; Teicher MH; Cohen DJ; Anderson GM; Young JG; Levitt P
    Psychopharmacology (Berl); 1984; 82(1-2):73-7. PubMed ID: 6420833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.